Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea · Delayed Price · Currency is KRW 3,515.00
-120.00 (-3.30%)
Jul 28, 2026, 3:30 PM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 223.7 billion as of July 28, 2026. Its market cap has decreased by -50.39% in one year.
Market Cap
223.70B
Enterprise Value
278.47B
Revenue
94.42B
Ranking
n/a
PE Ratio
26.15
Stock Price
3,515.00
ChartMarket Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 223.70B, a decrease of -50.44%. That is a compound annual growth rate of -13.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 216.31B | -30.12% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
| Sep 27, 2021 | 451.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InBody Co.,Ltd | 673.74B |
| i-SENS | 503.24B |
| WON TECH | 455.97B |
| ToolGen | 381.39B |
| Curexo | 346.17B |
| Value Added Technology | 260.99B |
| T&R Biofab | 117.73B |
| Osang Healthcare Co.,Ltd | 82.80B |